Glp-1ras

Jennifer Manne-Goehler, HIV clinician-scientist at the Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School, talks to us about the cardiometabolic complications of HIV, specifically cardiovascular disease, diabetes, and weight loss strategies for people...

* NAION cases have been reported for all currently marketed GLP-1 RA products. FDA concluded that there is a potential increased risk of rare NAION events in patients taking GLP-1 RAs. Based on these findings, FDA is requiring that application holders add information about the risk for NAION to...